These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7045329)

  • 21. Liposomes designed to avoid the reticuloendothelial system.
    Papahadjopoulos D; Gabizon A
    Prog Clin Biol Res; 1990; 343():85-93. PubMed ID: 2198586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modified in vivo behavior of liposomes containing synthetic glycolipids.
    Wu MS; Robbins JC; Bugianesi RL; Ponpipom MM; Shen TY
    Biochim Biophys Acta; 1981 Apr; 674(1):19-29. PubMed ID: 7236728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential applications of liposomes to therapy.
    Ryman BE; Jewkes RF; Jeyasingh K; Osborne MP; Patel HM; Richardson VJ; Tattersall MH; Tyrrell DA
    Ann N Y Acad Sci; 1978; 308():281-307. PubMed ID: 358897
    [No Abstract]   [Full Text] [Related]  

  • 24. Liposomes as active participants in experimental therapeutics.
    Ritter C; Rutman RJ
    Cancer Drug Deliv; 1984; 1(2):137-44. PubMed ID: 6544630
    [No Abstract]   [Full Text] [Related]  

  • 25. Liposome formulation of NSC-639829 using halothane as a solvent: a technical note.
    Jain A; Sanghvi T; Yalkowsky SH
    AAPS PharmSciTech; 2003 Oct; 4(4):E52. PubMed ID: 15198547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Feasibility of magnetic liposomes as a targeting device for drugs.
    Kiwada H; Sato J; Yamada S; Kato Y
    Chem Pharm Bull (Tokyo); 1986 Oct; 34(10):4253-8. PubMed ID: 3829157
    [No Abstract]   [Full Text] [Related]  

  • 27. Liposomes--problems and promise as selective drug carriers.
    Kaye SB
    Cancer Treat Rev; 1981 Mar; 8(1):27-50. PubMed ID: 7018681
    [No Abstract]   [Full Text] [Related]  

  • 28. Magnetic microspheres: a vehicle for selective targeting of drugs.
    Widder KJ; Senyei AE
    Pharmacol Ther; 1983; 20(3):377-95. PubMed ID: 6351115
    [No Abstract]   [Full Text] [Related]  

  • 29. [Experimental evaluation of tumor therapy with cytostatic agents deposited in the abdominal cavity in acetylcellulose].
    Chissov VI; Borisov VI; Rusakov IG; Shchitkov KG; Il'ina AI
    Eksp Onkol; 1987; 9(1):65-8. PubMed ID: 3816661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New trends and concepts in antineoplastic chemotherapy (Report from the 13th International Congress on Chemotherapy in Vienna)].
    Danysz A
    Pol Tyg Lek; 1984 Jul; 39(27):929-32. PubMed ID: 6149526
    [No Abstract]   [Full Text] [Related]  

  • 31. Anti-cancer activity of 9-nitrocamptothecin liposome aerosol in mice.
    Knight V; Koshkina N; Waldrep C; Giovanella BC; Kleinerman E; Gilbert B
    Trans Am Clin Climatol Assoc; 2000; 111():135-45. PubMed ID: 10881338
    [No Abstract]   [Full Text] [Related]  

  • 32. Quercetin-Decorated Curcumin Liposome Design for Cancer Therapy: In-Vitro and In-Vivo Studies.
    Ravichandiran V; Masilamani K; Senthilnathan B; Maheshwaran A; Wong TW; Roy P
    Curr Drug Deliv; 2017; 14(8):1053-1059. PubMed ID: 27572089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and use of ceramide nanoliposomes in cancer.
    Watters RJ; Kester M; Tran MA; Loughran TP; Liu X
    Methods Enzymol; 2012; 508():89-108. PubMed ID: 22449922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fighting cancer: from the bench to bedside using second generation cationic liposomal therapeutics.
    Campbell RB; Ying B; Kuesters GM; Hemphill R
    J Pharm Sci; 2009 Feb; 98(2):411-29. PubMed ID: 18563780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Experiment and clinical application of targeting treatment with adriamycin magnetic albumin microspheres in human gastric carcinoma].
    Tao K; Chen D; Wang G; Bai Z; Lu X; Tian Y; Wu Z; Hu F; Nie X
    Zhonghua Wai Ke Za Zhi; 1999 Apr; 37(4):205-7. PubMed ID: 11829819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multi-functional liposomes showing radiofrequency-triggered release and magnetic resonance imaging for tumor multi-mechanism therapy.
    Du B; Han S; Li H; Zhao F; Su X; Cao X; Zhang Z
    Nanoscale; 2015 Mar; 7(12):5411-26. PubMed ID: 25731982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting of liposomes to tumor cells in vivo.
    Papahadjopoulos D; Gabizon A
    Ann N Y Acad Sci; 1987; 507():64-74. PubMed ID: 3327419
    [No Abstract]   [Full Text] [Related]  

  • 38. 5-Fluoroorotate: a new liposome-dependent cytotoxic agent.
    Heath TD; Lopez NG; Stern WH; Papahadjopoulos D
    FEBS Lett; 1985 Jul; 187(1):73-5. PubMed ID: 4018256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and evaluation of a novel liposomal formulation of cisplatin.
    Zhou X; Wang J; Wu J; Yang X; Yung BC; Lee LJ; Lee RJ
    Eur J Pharm Sci; 2015 Jan; 66():90-5. PubMed ID: 25446511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug delivery in cancer using liposomes.
    Dass CR
    Methods Mol Biol; 2008; 437():177-82. PubMed ID: 18369969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.